Schroeder T
Neurol Res. 1986 Dec;8(4):231-6. doi: 10.1080/01616412.1986.11739760.
Cerebral blood flow (CBF), measured with a mobile 10 detector unit and non-invasive Xenon-133 technique, was investigated before and after cerebral vasodilation with acetazolamide (Diamox) in 78 patients prior to carotid endarterectomy. The change in side-to-side CBF asymmetry from baseline to Diamox study, the Diamox asymmetry enhancement, was compared with the intraoperatively measured cerebral perfusion pressures. Asymmetry enhancement exceeded the methodological variation in 14 patients, 13 of whom had a perfusion pressure below 65 mmHg. Insignificant asymmetry enhancement was found in 64 patients: 52 with unilateral and 12 with bilateral disease. Of these two and four patients, respectively, had perfusion pressures below 65 mmHg. Enhancement of CBF asymmetry following a potent cerebral vasodilator stimulus is a reliable predictor, in unilateral carotid artery disease, of critically reduced cerebral perfusion pressure.
在78例拟行颈动脉内膜切除术的患者中,使用移动式10探测器单元和非侵入性氙-133技术测量脑血流量(CBF),并在使用乙酰唑胺(醋氮酰胺)进行脑血管扩张前后进行研究。比较从基线到醋氮酰胺研究期间左右脑血流量不对称性的变化,即醋氮酰胺不对称性增强,并与术中测量的脑灌注压进行比较。14例患者的不对称性增强超过了方法学变异,其中13例患者的灌注压低于65 mmHg。64例患者发现不对称性增强不显著:52例为单侧疾病,12例为双侧疾病。这两组患者中分别有2例和4例患者的灌注压低于65 mmHg。在单侧颈动脉疾病中,强效脑血管扩张剂刺激后脑血流量不对称性增强是脑灌注压严重降低的可靠预测指标。